EIKON THERAPEUTICS

Serial Number 90690451
734

Registration Progress

Application Filed
May 4, 2021
Under Examination
Sep 27, 2022
Approved for Publication
Aug 2, 2022
Published for Opposition
Aug 2, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Sep 27, 2025 57 days
Statement of Use required (all extensions used)

Trademark Image

EIKON THERAPEUTICS

Basic Information

Serial Number
90690451
Filing Date
May 4, 2021
Published for Opposition
August 2, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Mar 27, 2025
Application
Pending
Classes
042

Rights Holder

EIKON THERAPEUTICS, INC.

03
Address
230 Harriet Tubman Way
Millbrae, CA 94030

Ownership History

EIKON THERAPEUTICS, INC.

Original Applicant
03
Hayward, CA

EIKON THERAPEUTICS, INC.

Owner at Publication
03
Millbrae, CA

Legal Representation

Attorney
Ilene B. Tannen

USPTO Deadlines

Next Deadline
57 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
September 27, 2025

Application History

43 events
Date Code Type Description Documents
Jun 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 27, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 30, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 30, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 5, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 5, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 4, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 26, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 22, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 20, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 20, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 20, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 2, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 13, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 25, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 25, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 25, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 25, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 6, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 6, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 5, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 13, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 13, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 13, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"